RBM7在乳腺癌细胞MDA-MB-231中的表达及其对AKAP12表达的影响
DOI:
作者:
作者单位:

1.南京医科大学第一附属医院 乳腺中心;2.南京医科大学第一附属医院 健康管理中心;3.南京医科大学第一附属医院 病理科

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金项目(面上项目,重点项目,重大项目)


The expression of RBM7 in breast cancer cell MDA-MB-231 and its effects on AKAP12 expression
Author:
Affiliation:

Breast Disease Center, The First Affiliated Hospital with Nanjing Medical University

Fund Project:

The National Natural Science Foundation of China (General Program, Key Program, Major Research Plan)

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探讨RNA结合蛋白7(RNA binding motif protein 7,RBM7)在人源性乳腺癌细胞MDA-MB-231中的表达,及其表达改变后对A激酶锚定蛋白12(A-Kinase Anchoring Protein 12,AKAP12)表达的影响。 方法:在人源性乳腺癌细胞MDA-MB-231中分别转染RBM7过表达、干扰慢病毒(实验组)和相应对照慢病毒(对照组),经嘌呤霉素筛选后获得稳定转染的细胞株,使用荧光显微镜观察细胞转染情况。通过实时荧光定量聚合酶链反应(Quantitative real time polymerase chain reaction,qRT-PCR)和蛋白质免疫印迹(Western blot)实验分别验证转染后的RBM7表达情况,并观察RBM7表达改变后对AKAP12表达的影响。经RNA测序(RNA-sequence,RNA-seq)获得的差异表达基因进行(Gene Ontology, GO)富集分析发现受RBM7影响的差异表达基因的主要富集通路,并结合UALCAN数据库分析AKAP12在乳腺癌中的表达情况。更进一步通过RNA结合蛋白免疫共沉淀(RNA binding protein immunoprecipitation,RIP)实验明确RBM7与AKAP12之间的关系。通过免疫组化(immunohistochemistry,IHC)在乳腺癌组织中明确RBM7的表达与AKAP12的表达之间的关系。 结果:在乳腺癌细胞MDA-MB-231中分别转染RBM7过表达、干扰慢病毒,经嘌呤霉素筛选2周后,获得RBM7过表达及干扰的稳转细胞株。经RNA-seq获得的差异表达基因进行GO富集分析发现,受RBM7显著影响的基因主要富集在细胞周期通路;且UALCAN数据库分析发现AKAP12在乳腺癌中低表达(p<0.05)。qRT-PCR和Western blot显示,RBM7过表达能下调AKAP12的RNA及蛋白的表达(p<0.05),RBM7干扰后能上调AKAP12的RNA及蛋白的表达(p<0.05)。RNA结合蛋白免疫共沉淀(RIP)实验显示,RBM7能直接结合AKAP12的mRNA从而发挥其对AKAP12的调节作用(p<0.05)。免疫组化亦显示,在人乳腺癌组织中RBM7表达与AKAP12表达呈显著负性关联(p<0.05)。 结论:RBM7在乳腺癌细胞(MDA-MB-231)和乳腺癌组织中下调AKAP12的表达。

    Abstract:

    Objective: To investigate the expression of RNA binding motif protein 7 (RBM7) in human breast cancer cell MDA-MB-231, and its effects on the expression of A kinase anchor protein 12 (AKAP12). Methods: MDA-MB-231 cells were respectively transfected with RBM7 overexpressing, knocking down lentivirus (experimental group) and corresponding control lentivirus (control group). Stable transfected cell lines were selected with puromycin and verified via fluorescence microscopy. Quantitative real time polymerase chain reaction (qRT-PCR) and Western blot assays were used to verify the expression of RBM7, and to investigate the effects of altered RBM7 expression on the expression of AKAP12. Gene Ontology (GO) enrichment analysis was performed on the differentially expressed genes obtained by RNA sequencing, and revealed significantly enriched pathways regulated by RBM7. At the same time, the UALCAN database was employed to assess AKAP12 expression in breast cancer. The relationship between RBM7 and AKAP12 was studied by RNA binding protein immunoprecipitation (RIP) assays. Furthermore, immunohistochemical analysis was performed to delineate the relationship between RBM7 and AKAP12 in breast cancer tissues. Results: RBM7 overexpression and knockdown lentiviruses were transfected in the breast cancer cell MDA-MB-231, respectively. Stable cell lines with RBM7 overexpression and knockdown were successfully established, within two weeks of puromycin selection. GO enrichment analysis of differentially expressed genes obtained by RNA-sequence revealed that RBM7-regulated genes were mainly enriched in the cell cycle pathway. Moreover, the UALCAN database analysis revealed that AKAP12 was lowly expressed in breast cancer (p<0.05). It was observed that overexpression of RBM7 could downregulate RNA and protein expression of AKAP12, and knockdown of RBM7 upregulated RNA and protein expression of AKAP12 via qRT-PCR and Western blot (p<0.05). RNA-binding protein immunoprecipitation (RIP) assays revealed that RBM7 could directly bind to mRNA of AKAP12 (p<0.05). Immunohistochemical analysis revealed an inverse correlation between RBM7 and AKAP12 expression in breast cancer tissues (p<0.05). Conclusion: RBM7 downregulated the expression of AKAP12 in breast cancer cell MDA-MB-231 and breast cancer tissues.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2025-08-27
  • 最后修改日期:2025-10-23
  • 录用日期:2025-12-16
  • 在线发布日期:
  • 出版日期:
关闭